Here are relevant reports on : peptide-synthesis-market
-
Active Pharmaceutical Ingredients (API) Market by type (Innovative, Generic), Synthesis (synthetic, biotech), Potency (HPAPI), Product (mAbs, hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive landscape - Global forecast to 2030
The global active pharmaceutical ingredient market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2024 to 2030, culminating in a forecasted valuation of US$198.39 billion by the end of the period. The growth of the active pharmaceutical ingredients market is driven by the surge in demand for complex APIs, such as high-potency API, peptides, oligonucleotides, and increasing government incentives and supply chain reshoring.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Sugar Substitutes Market by Type (HFCS, High-intensity Sweeteners, Low-Intensity Sweeteners), Manufacturing Technology (Precision Fermentation, Enzymatic Conversion, Chemical Synthesis), Application, Form, Source, Region - Global Forecast to 2029
The sugar substitutes market is projected to reach USD 29.90 billion by 2029, at a CAGR of 4.9% during the forecast period. The report profiles key players such as Cargill, Incorporated (US), ADM (US), Ingredion (US), International Flavors & Fragrances Inc (US), Tate & Lyle (UK), Ajinomoto Co. Inc (Japan), GLG Life Tech Corp (Canada), Celanese Corporation (US), Roquette Frères (France), PCIPL (India), Mane SA. (France), Döhler GmbH (Germany), Morita Kagaku Kogyo Co., Ltd (Japan), zuChem (US), and Van Wankum Ingredients (Netherlands).
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Europe Oligonucleotide Synthesis Market by Product (Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic, Research, Diagnostics) - Forecast to 2030
The Europe Oligonucleotide Synthesis market, valued at USD 2.68 billion in 2024, stood at USD 3.17 billion in 2025 and is projected to advance at a resilient CAGR of 18.7% from 2025 to 2030, culminating in a forecasted valuation of USD 7.49 billion by the end of the period. The market is growing due to strong demand from therapeutics, diagnostics, and research.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
High Potency APIs Market / HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) & Region - Global Forecast to 2027
The global high potency APIs market growth is primed to transition from $24.5 billion in 2022 to $39.6 billion by 2027, showcasing a strong CAGR of 10.1%. This growth is driven by increasing demand for oncology drugs, advancements in HPAPI manufacturing technologies, and the rising focus on precision medicine.
- Published: May 2022
- Price: $ 4950
- TOC Available:
-
Bromine Market by Derivative (Organobromine, Clear Brine Fluids and Hydrogen Bromide), Application (Flame Retardant, PTA Synthesis, Oil & Gas Drilling, Water Treatment & Biocides, HBR Flow Battery, Pesticides), and Region - Global Forecast to 2030
The global bromine market is projected to grow from USD 2.86 billion in 2025 to USD 3.76 billion by 2030, at a CAGR of 5.6% during the forecast period. Some of the leading players in this market include ICL (Israel), Albemarle Corporation (US), LANXESS (Germany), Jordan Bromine Company (Jordan), and Tosoh Corporation (Japan).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Dimethyl Carbonate Market by Application (Polycarbonate Synthesis, Battery Electrolyte, Solvents, Reagents), End-use Industry (Plastics, Paints & Coatings, Pharmaceutical), Grade (Industry, Pharmaceutical, Battery), and Region - Global Forecast to 2030
The global dimethyl carbonate market is projected to grow from USD 1.56 billion in 2025 to USD 2.63 billion by 2030, at a CAGR of 11.1% during the forecast period. Leading players in this market include UBE Corporation (Japan), LOTTE Chemical Corporation (South Korea), Shinghwa Advanced Material Group Co.,Ltd. (China), Sankyo Chemical Corporation (Japan), Shandong AIVK Chemical Co., Ltd. (China), Hi-tech Spring (China), Shandong depu chemical industry science&technology co.,ltd (China), Enam Organics India Ltd (India), Shandong Hualu Hengsheng Group Co.(China), Zhengzhou Meiya Chemical Products Co. (China), Shandong Daze Chemical Group (China), Shandong Longze Chemical Co.,Ltd (China), Shandong Wanling Chemical Co. LTD (China), Haihang Industry (China), Shandong Chemical Co., Ltd. (China), and Henan GP Chemicals Co. (China).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
North America Oligonucleotide Synthesis Market by Product [(Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type (Custom, Predesigned), Reagents, Equipment), Application (Therapeutic, Research, Diagnostics)] - Forecast to 2030
The North America Oligonucleotide Synthesis market, valued at USD4.02 billion in 2024, stood at USD4.77 billion in 2025 and is projected to advance at a resilient CAGR of 18.9% from 2025 to 2030, culminating in a forecasted valuation of USD11.34 billion by the end of the period. The market is growing due to the strong demand from therapeutics, diagnostics and research. Pharma and biotech end users require high-purity DNA/RNA oligos for siRNA, antisense, aptamers and guide RNAs for gene editing.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Acetonitrile Market by Type (Derivative, Solvent), Application (Organic Synthesis, Analytical Applications, Extraction), End-use Industry (Pharmaceutical, Analytical industry, Agrochemical), Region - Global Forecast to 2028
The acetonitrile market is expected to grow from USD 439 million in 2023 to USD 595 million by 2028, at a CAGR of 6.2% during the forecast period. Prominent companies in the acetonitrile market include INEOS AG (Switzerland.), Asahi Kasei Corporation (Japan), Nova Molecular Technologies (US), PetroChina Co. Ltd. (China), Formosa Plastic Corporation (Taiwan), ShengHong Petrochemical Group Co. Ltd. (China), Avantor Performance Materials LLC (US), Imperial Chemical Corporation (Taiwan), Tedia Company Inc. (US), Avantor Performance Materials, LLC (US), Shanghai Secco Petrochemical Company Limited (China), Qingdao Shida Chemical Co., Ltd. (China), Nantong Acetic Acid Chemical Co., Ltd. (China), and others.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Asia Pacific Oligonucleotide Synthesis Market by Product {Drugs [ASO, siRNA], Synthesized Oligos [Product (Primers, Probes), Type (Custom, Predesigned)], Reagents, Equipment}, Application (Therapeutic, Research, Diagnostics) - Forecast to 2030
The Asia Pacific Oligonucleotide Synthesis market, valued at USD 1.76 billion in 2024, stood at USD 2.08 billion in 2025 and is projected to advance at a resilient CAGR of 18.5% from 2025 to 2030, culminating in a forecasted valuation of USD 4.88 billion by the end of the period. This expansion is driven by increasing demand from therapeutics, diagnostics, and research.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Global Forecast to 2028
The global microbiome sequencing services market, valued at US$250 million in 2022, stood at US$284 million in 2023 and is projected to advance at a resilient CAGR of 14.3% from 2023 to 2028, culminating in a forecasted valuation of US$555 billion by the end of the period. Growth in this market is primarily driven by the increasing demand for metagenomic sequencing, the growing focus on the development of human microbiome therapeutics, and the high cost of advanced sequencing infrastructure.
- Published: May 2023
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
